NEW YORK (GenomeWeb News) – Waters has sold $200 million in senior notes in a private placement, it said in a filing with the US Securities and Exchange Commission today.

The firm sold three series of notes in the placement: $100 million of 3.4 percent Series F Senior Notes, due June 30, 2021; $50 million of 3.92 percent Series G Senior Notes, due June 30, 2024; and $50 million of Series H Floating Rate Senior Notes bearing interest at 3 month LIBOR plus 1.25 percent, due June 30, 2024.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.

Jul
12
Sponsored by
Canon BioMedical

This webinar will discuss a project that is analyzing the “Human Brainome” – genome, transcriptome, proteome, and phenome interaction data -- to gain insights into Alzheimer’s disease pathogenesis.